118 related articles for article (PubMed ID: 38488171)
21. Fecal calprotectin is a useful screening parameter for hepatic encephalopathy and spontaneous bacterial peritonitis in cirrhosis.
Gundling F; Schmidtler F; Hapfelmeier A; Schulte B; Schmidt T; Pehl C; Schepp W; Seidl H
Liver Int; 2011 Oct; 31(9):1406-15. PubMed ID: 22093455
[TBL] [Abstract][Full Text] [Related]
22. Serum endotoxin and inflammatory mediators in patients with cirrhosis and hepatic encephalopathy.
Jain L; Sharma BC; Sharma P; Srivastava S; Agrawal A; Sarin SK
Dig Liver Dis; 2012 Dec; 44(12):1027-31. PubMed ID: 22883217
[TBL] [Abstract][Full Text] [Related]
23. Secondary prophylaxis of hepatic encephalopathy in cirrhosis of liver: a double-blind randomized controlled trial of L-ornithine L-aspartate versus placebo.
Varakanahalli S; Sharma BC; Srivastava S; Sachdeva S; Dahale AS
Eur J Gastroenterol Hepatol; 2018 Aug; 30(8):951-958. PubMed ID: 29727385
[TBL] [Abstract][Full Text] [Related]
24. Raised serum Interleukin-6 identifies patients with liver cirrhosis at high risk for overt hepatic encephalopathy.
Labenz C; Toenges G; Huber Y; Nagel M; Marquardt JU; Schattenberg JM; Galle PR; Labenz J; Wörns MA
Aliment Pharmacol Ther; 2019 Nov; 50(10):1112-1119. PubMed ID: 31583743
[TBL] [Abstract][Full Text] [Related]
25. Identification of bacterial DNA in neutrocytic and non-neutrocytic cirrhotic ascites by means of a multiplex polymerase chain reaction.
Bruns T; Sachse S; Straube E; Assefa S; Herrmann A; Hagel S; Lehmann M; Stallmach A
Liver Int; 2009 Sep; 29(8):1206-14. PubMed ID: 19602138
[TBL] [Abstract][Full Text] [Related]
26. Bispectral index monitoring for diagnosis and assessment of severity of hepatic encephalopathy in cirrhotic patients.
Jindal A; Sharma BC; Sachdeva S; Chawla R; Srivastava S; Maharshi S
Dig Liver Dis; 2015 Sep; 47(9):769-74. PubMed ID: 26022229
[TBL] [Abstract][Full Text] [Related]
27. Detection and identification of bacterial DNA in patients with cirrhosis and culture-negative, nonneutrocytic ascites.
Such J; Francés R; Muñoz C; Zapater P; Casellas JA; Cifuentes A; Rodríguez-Valera F; Pascual S; Sola-Vera J; Carnicer F; Uceda F; Palazón JM; Pérez-Mateo M
Hepatology; 2002 Jul; 36(1):135-41. PubMed ID: 12085357
[TBL] [Abstract][Full Text] [Related]
28. Hepatic encephalopathy is related to anemia and fat-free mass depletion in liver transplant candidates with cirrhosis.
Kalaitzakis E; Josefsson A; Castedal M; Henfridsson P; Bengtsson M; Andersson B; Björnsson E
Scand J Gastroenterol; 2013 May; 48(5):577-84. PubMed ID: 23452072
[TBL] [Abstract][Full Text] [Related]
29. Minimal hepatic encephalopathy and critical flicker frequency are associated with survival of patients with cirrhosis.
Ampuero J; Simón M; Montoliú C; Jover R; Serra MÁ; Córdoba J; Romero-Gómez M
Gastroenterology; 2015 Nov; 149(6):1483-9. PubMed ID: 26299413
[TBL] [Abstract][Full Text] [Related]
30. Association between diabetes mellitus and hepatic encephalopathy in patients with cirrhosis.
Labenz C; Nagel M; Kremer WM; Hilscher M; Schilling CA; Toenges G; Kuchen R; Schattenberg JM; Galle PR; Wörns MA
Aliment Pharmacol Ther; 2020 Aug; 52(3):527-536. PubMed ID: 32598080
[TBL] [Abstract][Full Text] [Related]
31. Proton Pump Inhibitors Are Associated With Minimal and Overt Hepatic Encephalopathy and Increased Mortality in Patients With Cirrhosis.
Nardelli S; Gioia S; Ridola L; Farcomeni A; Merli M; Riggio O
Hepatology; 2019 Aug; 70(2):640-649. PubMed ID: 30289992
[TBL] [Abstract][Full Text] [Related]
32. Probiotics prevent hepatic encephalopathy in patients with cirrhosis: a randomized controlled trial.
Lunia MK; Sharma BC; Sharma P; Sachdeva S; Srivastava S
Clin Gastroenterol Hepatol; 2014 Jun; 12(6):1003-8.e1. PubMed ID: 24246768
[TBL] [Abstract][Full Text] [Related]
33. Haemodynamic derangement in human immunodeficiency virus-infected patients with hepatitis C virus-related cirrhosis: the role of bacterial translocation.
Montes-de-Oca M; Blanco MJ; Marquez M; Soto MJ; Fernandez-Gutiérrez C; Rodriguez-Ramos C; Giron-Gonzalez JA
Liver Int; 2011 Jul; 31(6):850-8. PubMed ID: 21645216
[TBL] [Abstract][Full Text] [Related]
34. The impact of bacterial DNA translocation on early postoperative outcomes in Crohn's patients undergoing abdominal surgery.
Li Y; Zuo L; Zhu W; Gong J; Zhang W; Gu L; Guo Z; Li N; Li J
J Crohns Colitis; 2015 Mar; 9(3):259-65. PubMed ID: 25555386
[TBL] [Abstract][Full Text] [Related]
35. Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: results of a placebo-controlled, double-blind study.
Kircheis G; Nilius R; Held C; Berndt H; Buchner M; Görtelmeyer R; Hendricks R; Krüger B; Kuklinski B; Meister H; Otto HJ; Rink C; Rösch W; Stauch S
Hepatology; 1997 Jun; 25(6):1351-60. PubMed ID: 9185752
[TBL] [Abstract][Full Text] [Related]
36. Effect of probiotic treatment on cirrhotic patients with minimal hepatic encephalopathy: A meta-analysis.
Cao Q; Yu CB; Yang SG; Cao HC; Chen P; Deng M; Li LJ
Hepatobiliary Pancreat Dis Int; 2018 Feb; 17(1):9-16. PubMed ID: 29428113
[TBL] [Abstract][Full Text] [Related]
37. International normalized ratio and Model for End-stage Liver Disease score predict short-term outcome in cirrhotic patients after the resolution of hepatic encephalopathy.
Hu XP; Gao J
World J Gastroenterol; 2019 Jul; 25(26):3426-3437. PubMed ID: 31341366
[TBL] [Abstract][Full Text] [Related]
38. Increased lipopolysaccharide binding protein in cirrhotic patients with marked immune and hemodynamic derangement.
Albillos A; de la Hera A; González M; Moya JL; Calleja JL; Monserrat J; Ruiz-del-Arbol L; Alvarez-Mon M
Hepatology; 2003 Jan; 37(1):208-17. PubMed ID: 12500206
[TBL] [Abstract][Full Text] [Related]
39. Characteristics, risk factors, and mortality of cirrhotic patients hospitalized for hepatic encephalopathy with and without acute-on-chronic liver failure (ACLF).
Cordoba J; Ventura-Cots M; Simón-Talero M; Amorós À; Pavesi M; Vilstrup H; Angeli P; Domenicali M; Ginés P; Bernardi M; Arroyo V;
J Hepatol; 2014 Feb; 60(2):275-81. PubMed ID: 24128414
[TBL] [Abstract][Full Text] [Related]
40. Infection and systemic inflammation, not ammonia, are associated with Grade 3/4 hepatic encephalopathy, but not mortality in cirrhosis.
Shawcross DL; Sharifi Y; Canavan JB; Yeoman AD; Abeles RD; Taylor NJ; Auzinger G; Bernal W; Wendon JA
J Hepatol; 2011 Apr; 54(4):640-9. PubMed ID: 21163546
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
